Concepedia

Lijun Sun

LS

Statistics

Publications

36

Citations

1.6K

H-Index

22

Active since

1994

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Synta Pharmaceuticals (United States)

Emory University

Cancer Research Institute

Lijun Sun is an author at Beth Israel Deaconess Medical Center specializing in medicinal chemistry, drug discovery, and chemistry.

ORCID

Publications per year

1994–2024

36

Publications

36

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

Weiwen Ying, Zhenjian Du, Lijun Sun et al. · Molecular Cancer Therapeutics · 2011 · 231 citations

, , +11

Synthesis and anticancer activity of novel water soluble benzimidazole carbamates

Jae Eun Cheong, Michela Zaffagni, Ivy Chung et al. · European Journal of Medicinal Chemistry · 2017 · 115 citations

, , +10

Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines

David A. James, Keizo Koya, Hao Li et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 105 citations

, , +12

Reversal of the Malignant Phenotype of Gastric Cancer Cells by Inhibition of RhoA Expression and Activity

Na Liu, Feng Bi, Yanglin Pan et al. · Clinical Cancer Research · 2004 · 99 citations

, , +17

Glycopeptide analogues of PSGL-1 inhibit P-selectin in vitro and in vivo

Venkata R. Krishnamurthy, Mohammed Y. R. Sardar, Yu Ying et al. · Nature Communications · 2015 · 93 citations · Full text

, , +17

1–5 of 36